Perrigo Co (Perrigo Co) Net Margin %

: -2.79% (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Perrigo Co's Net Income for the three months ended in Dec. 2023 was $-32 Mil. Perrigo Co's Revenue for the three months ended in Dec. 2023 was $1,157 Mil. Therefore, Perrigo Co's net margin for the quarter that ended in Dec. 2023 was -2.79%.

The historical rank and industry rank for Perrigo Co's Net Margin % or its related term are showing as below:

PRGO' s Net Margin % Range Over the Past 10 Years
Min: -75.99 Med: 1.08 Max: 5.95
Current: -0.27

PRGO's Net Margin % is ranked worse than
60.65% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.77 vs PRGO: -0.27

Perrigo Co Net Margin % Historical Data

The historical data trend for Perrigo Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

3.78

-3.98

-1.66

-3.16

-0.27

Perrigo Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															-2.05	-0.25	0.70	1.26	-2.79

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perrigo Co Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Net Margin % falls into.

Perrigo Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Perrigo Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-12.7	/	4655.6
	=	-0.27 %

Perrigo Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-32.3	/	1156.9
	=	-2.79 %

Perrigo Co (NYSE:PRGO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Perrigo Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Perrigo Co (Perrigo Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (NYSE:PRGO) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

PIG:Germany

Address

The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74

Website

https://www.perrigo.com

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Executives

Robert Willis	officer: Acting CHRO	C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Alison Ives	officer: EVP & Chief Scientific Officer	C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Eduardo Guarita Bezerra	officer: EVP & Chief Financial Officer	C/O FRESH DEL MONTE PRODUCE INC., PO BOX 149222, CORAL GABLES FL 33134
Patrick Lockwood-taylor	director, officer: CEO	C/O PERRIGO COMPANY PLC, 430 MONROE AVE NW, GRAND RAPIDS MI 49503
Julia M Brown	director	C/O ABLE BRANDS CO., 30 HUDSON YARDS, NEW YORK NY 10001
Triona Schmelter	officer: EVP & President CSCA	2021 SPRING ROAD, SUITE 600, OAK BROOK IL 60523
Geoffrey M. Parker	director	15 RIORDAN PLACE, MENLO PARK CA 94025
Svend Andersen	director	C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Murray S Kessler	director, officer: CEO	714 GREEN VALLEY ROAD, GREENSBORO NC 27408
Thomas Farrington	officer: Senior VP and CIO	4012 W. CANTERBURY CT., NEQUON WI 53092
Dillard James E Iii	officer: EVP, Chief Scientific Officer	6601 WEST BROAD STREET, RICHMOND VA 23230
Ronald Craig Janish	officer: EVP, Global Op. & Supply Chain	PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Grainne Quinn	officer: EVP, Chief Medical Officer	PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Albert Manzone	director	C/O MERISANT, AVENUE JEAN-JACQUES ROUSSEAU 7, NEUCHATEL V8 CH-2000
Kyle Hanson	officer: EVP & General Counsel